Phytochem Remedies IPO GMP has become a hot topic among SME IPO investors who actively track live IPO GMP to identify potential listing opportunities. The IPO has attracted attention due to its reasonable issue size, fixed price structure, and growing interest in the pharmaceutical and herbal remedies space.
As per details available on Finowings, Phytochem Remedies IPO is a fixed-price SME IPO worth ₹38.22 crore, comprising 100% fresh issue of 0.39 crore equity shares. Since there is no Offer for Sale (OFS), the entire IPO proceeds will be utilized to strengthen the company’s business operations, working capital needs, and future growth plans.
Phytochem Remedies IPO Key Dates (As per Finowings)
IPO Opening Date: December 18, 2025
IPO Closing Date: December 22, 2025
Allotment Date: December 23, 2025
Listing Date: December 26, 2025
Stock Exchange: BSE SME
Investors tracking upcoming IPO GMP and current IPO GMP should keep these dates in mind for timely application and allotment checks.
Phytochem Remedies IPO Price, Lot Size & Investment Details
IPO Price: ₹98 per share
Face Value: ₹10 per share
Lot Size: 1,200 shares
Minimum Investment Required
Retail Investors:
Minimum application: 2 lots (2,400 shares)
Investment amount: ₹2,35,200
HNI Investors:
Minimum application: 3 lots (3,600 shares)
Investment amount: ₹3,52,800
Due to the higher ticket size typical of SME IPOs, investors should assess liquidity and risk before applying.
Phytochem Remedies IPO GMP Today – Grey Market Trend
The Phytochem Remedies IPO GMP indicates the premium at which shares are trading in the unofficial grey market before listing. IPO GMP today helps investors gauge market sentiment and potential listing performance.
As tracked by Finowings IPO GMP, grey market premium reflects demand but does not guarantee listing gains. GMP can change rapidly based on subscription data, overall market conditions, and SME investor sentiment.
Note: IPO GMP is unofficial and unregulated. It should be used only as a sentiment indicator, not as the sole basis for investment decisions.
Why Investors Are Watching Phytochem Remedies IPO GMP Closely
SME IPO with 100% fresh issue, ensuring funds go directly to business growth
Presence in the phytochemical and remedies segment, which aligns with long-term healthcare demand
Fixed price IPO offers clarity on valuation
Increasing interest among investors tracking live GMP IPO and latest IPO GMP updates
Important Things to Consider Before Investing
Before relying only on Phytochem Remedies IPO GMP, investors should also evaluate:
Company’s business model and product portfolio
Revenue growth and profitability trends
Industry outlook and competition
SME IPO risks such as lower liquidity and higher volatility
A balanced approach combining Finowings IPO analysis, GMP trends, and fundamental evaluation can help in making an informed decision.
Final Thoughts on Phytochem Remedies IPO GMP
The Phytochem Remedies IPO GMP today provides useful insight into market expectations, but it should always be backed by thorough research. SME IPOs can offer strong listing opportunities, yet they also carry higher risk compared to mainboard IPOs.
For live IPO GMP, upcoming IPO GMP, and current IPO GMP updates, investors can rely on Finowings for timely and accurate information.
Disclaimer:
IPO investments are subject to market risks. Grey Market Premium (GMP) is not an official indicator. Please consult a financial advisor before investing.
Post a Comment